ArticleNeuro-oncology advances
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.
David Rieger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.